SIREN : 800294407
CAROPHARM is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ALBI (81000), this company of category PME shows in 2017 a revenue of 663 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | 663 304 € |
| Net income | -5 906 € | 4 307 € | 240 158 € | 30 313 € | 40 307 € | 19 768 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | 19 102 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | 3.0% |
In 2024, CAROPHARM records a net loss of 6 k€. This deficit will reduce equity on the balance sheet.
-5 906 €
The debt ratio (= Financial debt / Equity x 100) stands at 44%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
44.426%
50.632%
42.0%
In 2024, the debt ratio of CAROPHARM (44.43) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of CAROPHARM (50.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 198.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
198.642
In 2024, the liquidity ratio of CAROPHARM (198.64) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Compare CAROPHARM with other companies in the same sector:
The revenue of CAROPHARM in 2017 is 663 k€.
CAROPHARM recorded a net loss in 2024.
The headquarters of CAROPHARM is located in ALBI (81000), in the department Tarn.
The tax return of CAROPHARM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CAROPHARM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.